Private Wealth Asset Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.68K Hold
124
﹤0.01% 734
2026
Q1
$6.3K Sell
124
-3
-2% -$140 ﹤0.01% 762
2025
Q4
$3.75K Hold
127
﹤0.01% 787
2025
Q3
$3.28K Hold
127
﹤0.01% 782
2025
Q2
$3.5K Sell
127
-20
-14% -$527 ﹤0.01% 790
2025
Q1
$4.17K Buy
+147
New +$5.22K ﹤0.01% 753

Other funds holding MRNA

Private Wealth Asset Management's MRNA Position: Q2 2026 in Review

Private Wealth Asset Management held its Moderna (MRNA) position steady in Q2 2026 at 124 shares worth $8.68K. The position accounts for ﹤0.01% of the portfolio, ranked #734.

Private Wealth Asset Management first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Private Wealth Asset Management held 124 shares of Moderna worth $8.68K as of Q2 2026.
  • Private Wealth Asset Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q2 2026, its #734 holding.
  • Private Wealth Asset Management first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.